Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

MPLT vs RLMD: stock comparison and AI forecast

Maplight Therapeutics, Inc. (MPLT) and Relmada Therapeutics, Inc. (RLMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

MPLT Maplight Therapeutics, Inc.

Market Cap
$385M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

RLMD Relmada Therapeutics, Inc.

Market Cap
$402M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

MPLT · RLMD

Key facts

  • MPLT and RLMD have similar market capitalizations ($385M and $402M).
  • MPLT carries 0.06 times debt per unit of equity, against 0.06 times for RLMD.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricMPLTRLMD
Market Cap$385M$402M
P/B Ratio1.11x1.95x
EPS$-21.22$-1.26
Book Value/Share$6.27$1.94
FCF/Share$-4.22–

Profitability & Margins

MetricMPLTRLMD
ROIC-85.1%-30.8%

Financial Health

MetricMPLTRLMD
Current Ratio16.52x29.52x
D/E Ratio0.06x0.06x
Financial Leverage1.06x1.06x
Interest Coverage–-21.3x
Working Capital$299M$212M

Cash Flow

MetricMPLTRLMD
Operating Cash Flow-$234M-$46M
Free Cash Flow-$235M–
Capital Spending-$520K–

Income Statement

MetricMPLTRLMD
Operating Income-$297M-$65M
R&D Expense$245M$29M

Dividend & Shareholder Information

MetricMPLTRLMD
Shares Outstanding56M107M
FAQ

MPLT vs RLMD: stock comparison and AI forecast

Which is bigger, MPLT or RLMD?

MPLT and RLMD have similar market capitalizations ($385M and $402M).

Which one does Intratio's AI model rank higher, MPLT or RLMD?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.